Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
Int J Mol Sci. 2019 Jul 24;20(15):3611. doi: 10.3390/ijms20153611.
Autism Spectrum Disorder (ASD) is a developmental condition characterized by impaired communication and obsessive behavior that affects 1 in 59 children. ASD is expected to affect 1 in about 40 children by 2020, but there is still no distinct pathogenesis or effective treatments. Prenatal stress has been associated with higher risk of developing ASD in the offspring. Moreover, children with ASD cannot handle anxiety and respond disproportionately even to otherwise benign triggers. Stress and environmental stimuli trigger the unique immune cells, mast cells, which could then trigger microglia leading to abnormal synaptic pruning and dysfunctional neuronal connectivity. This process could alter the "fear threshold" in the amygdala and lead to an exaggerated "fight-or-flight" reaction. The combination of corticotropin-releasing hormone (CRH), secreted under stress, together with environmental stimuli could be major contributors to the pathogenesis of ASD. Recognizing these associations and preventing stimulation of mast cells and/or microglia could greatly benefit ASD patients.
自闭症谱系障碍(ASD)是一种发育障碍,其特征是沟通障碍和强迫行为,影响每 59 名儿童中就有 1 名。预计到 2020 年,每 40 名儿童中就会有 1 名患有 ASD,但目前仍没有明确的发病机制或有效的治疗方法。产前应激与后代患 ASD 的风险增加有关。此外,患有 ASD 的儿童无法应对焦虑,即使是良性的触发因素也会做出过度反应。压力和环境刺激会引发独特的免疫细胞——肥大细胞,进而引发小神经胶质细胞,导致异常的突触修剪和功能失调的神经元连接。这个过程可能会改变杏仁核中的“恐惧阈值”,并导致过度的“战斗或逃跑”反应。在应激下分泌的促肾上腺皮质激素释放激素(CRH)与环境刺激一起,可能是 ASD 发病机制的主要因素。认识到这些关联,并防止肥大细胞和/或小神经胶质细胞的刺激,可能会使 ASD 患者大大受益。